| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |